Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 320

1.

Diversity of immunological phenotypes of lymphoblastic lymphoma.

Cossman J, Chused TM, Fisher RI, Magrath I, Bollum F, Jaffe ES.

Cancer Res. 1983 Sep;43(9):4486-90.

2.
3.

Terminal deoxynucleotidyl transferase positive lymphoblastic lymphoma: a study of 15 cases.

Long JC, McCaffrey RP, Aisenberg AC, Marks SM, Kung PC.

Cancer. 1979 Dec;44(6):2127-39.

4.

Monoclonal antibody studies in B(non-T)-cell malignancies.

Shimoyama M, Minato K, Tobinai K, Nagai M, Hirose M.

Jpn J Clin Oncol. 1983 Sep;13(3):477-88.

PMID:
6417373
5.

Antigenically defined subgroups of lymphoblastic lymphoma. Relationship to clinical presentation and biologic behavior.

Sheibani K, Nathwani BN, Winberg CD, Burke JS, Swartz WG, Blayney D, van de Velde S, Hill LR, Rappaport H.

Cancer. 1987 Jul 15;60(2):183-90.

6.

Cell surface markers in leukemia: biological and clinical correlations.

Thiel E.

Crit Rev Oncol Hematol. 1985;2(3):209-60. Review.

PMID:
3013441
7.
8.

Relevance of 3A1 monoclonal antibody in the diagnosis of T-cell acute lymphoblastic leukemia.

Lopez M, De Rossi G, Bonomo G, Napolitano M, Pasqualetti D, Guglielmi C, Annino L, Pandolfi F.

Diagn Immunol. 1985;3(1):11-4.

PMID:
3873317
9.

The application of monoclonal antibodies to the characterization and diagnosis of lymphoid neoplasms: a review of recent studies.

Knowles DM 2nd, Dodson LD, Raab R, Mittler RS, Talle MA, Goldstein G.

Diagn Immunol. 1983;1(3):142-9.

PMID:
6333955
10.

Immunopathology of non-Hodgkin lymphomas.

Huber H, Gattringer C, Knapp W, Stein H.

Klin Wochenschr. 1984 Nov 2;62(21):1001-10.

PMID:
6392723
11.

Lymphoblastic lymphoma with the phenotype of common acute lymphoblastic leukemia.

Borowitz MJ, Croker BP, Metzgar RS.

Am J Clin Pathol. 1983 Mar;79(3):387-91.

12.

Immunologic complexity of lymphoblastic lymphoma.

Grogan T, Spier C, Wirt DP, Hicks MJ, Paquin M, Hutter J, Miller T, Rangel C, Richter L, Jones S.

Diagn Immunol. 1986;4(2):81-8.

PMID:
3086016
13.

Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.

Habeshaw JA, Catley PF, Stansfeld AG, Brearley RL.

Br J Cancer. 1979 Jul;40(1):11-34.

14.

Immune marker expression in 53 lymphomas of high-grade malignancy.

Pallesen G, Madsen M, Schifter S.

Histopathology. 1983 Nov;7(6):841-57.

PMID:
6689315
16.

Surface immunoglobulin-positive lymphoblastic lymphoma. A report of three cases.

Stroup R, Sheibani K, Misset JL, Szekely AM, Tremblay G, Rappaport H.

Cancer. 1990 Jun 1;65(11):2559-63.

18.

Peripheral T-cell lymphoma: aggressive disease with heterogeneous immunotypes.

Grogan TM, Fielder K, Rangel C, Jolley CJ, Wirt DP, Hicks MJ, Miller TP, Brooks R, Greenberg B, Jones S.

Am J Clin Pathol. 1985 Mar;83(3):279-88.

19.

Expression of leukocyte common antigen in lymphoblastic lymphoma and small noncleaved undifferentiated non-Burkitt's lymphoma: an immunohistochemical study.

Van Eyken P, De Wolf-Peeters C, Van den Oord J, Tricot G, Desmet V.

J Pathol. 1987 Apr;151(4):257-61.

PMID:
2953875
20.

Non-Hodgkin's lymphoma phenotyping: problems in the use of heterologous and monoclonal antibodies.

Barcos M, Minowada J, Minato K, Pollard C, Cancino M, Han T, Henderson E, Ozer H.

Leuk Res. 1983;7(4):523-37.

PMID:
6604849
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk